An oncogenic CTNNB1 mutation is predictive of post-operative recurrence-free survival in an EGFR-mutant lung adenocarcinoma. Kim Y, Ahn B, Yoon S, Lee G, et al. PLoS One 2023;18:e0287256.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Kim Y, Ahn B, Yoon S, Lee G, et al. An oncogenic CTNNB1 mutation is predictive of post-operative recurrence-free survival in an EGFR-mutant lung adenocarcinoma. PLoS One 2023;18:e0287256.
PMID: 37347751